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Abstract 
Antibiotics are substances produced by bacteria or fungi that are inhibitory to other bacteria 
and fungi.  Antimicrobial compounds include substances that are naturally produced, chemically 
modified or completely synthetic (chemically designed or synthesized).  The chemical 
modification of naturally produced antibiotic generally results in increase stability, solubility, 
increased spectrum of activity, or efficacy.  Antimicrobial compounds are used in animals to 
treat and control infectious diseases, and also for growth promotion.  Bacteria may gain 
resistance to antibacterial agents via a variety of mechanisms.  There is growing evidence that 
antimicrobial resistance has significant public health consequences.  Rationale use of 
antimicrobial drugs using appropriate medication at the proper dosage and for duration is one of 
the important means to reduce selective pressure that helps reduce life of resistant organism.  It is 
also vital to reduce the spread of multi drug resistant organisms in the environment especially in 
health care facilities.  Bacteria evolve rapidly not only by mutation, but also by horizontal gene 
transfer through the transformation, transduction, and conjugation.  Conjugation involves a close 
contact between two bacteria and transfer of the plasmid that carry many genetic elements.  The 
pathogenic bacteria have the ability to sense as well as respond to the stress in the recipient. The 
epinephrine and norepinephrine play a key role in stress situations in animals.  A previous study 
showed that norepinephrine (NE), a catecholamine at physiological concentrations promoted the 
conjugation efficiencies of a conjugative plasmid from a clinical strain of Salmonella 
typhimurium to an E. coli recipient in vitro.  The objective of this study was to determine the 
effect of norepinephrine on conjugation of two E. coli strains. Both filter mating and liquid 
mating assays were used.  The results revealed that there was no significance difference between 
the presence and the absence of norepinephrine on conjugative transfer of RP4 plasmid between 
E. coli strains (FS1290 and C600N) either in filter mating or liquid mating.  Further studies are 
needed to determine whether higher concentration of (more than 20 mM) has any effects on 
conjugation in E. coli. 
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Chapter 1 - Literature Review 
Antibiotics and Antimicrobial agents 
 Antibiotics are substances produced by bacteria or fungi that are inhibitory to prokaryotes 
and eukaryotes (Kohanski et al., 2010).  Inhibition of bacteria and fungi results in killing or 
prevention of growth by targeting cellular processes, and the compounds generally cause little or 
no damage to the recipient (Prescott, 2000; Walsh, 2003; Giguere, 2006; Guardabassi and 
Courvalin, 2006).  Because of the limitation of the nutrient in the environment, there is usually a 
competition between microorganisms, which is one of the reasons why some organisms produce 
the antibiotics to have a competitive advantage to survive.  Antibiotics can be naturally produced 
by bacteria, fungi, or chemically modified compound that is produced naturally or completely 
synthetic (chemically designed or synthesized).  The chemical modification of naturally 
produced antibiotic generally results in increase stability, solubility, increased spectrum of 
activity, or efficacy (Hemaiswarya et al., 2008).  A number of semisynthetic penicillins and 
cephalosporins have been developed which have increased the spectrum of activity, long acting, 
and less likely to become resistant (Miller, 2008).  The term antimicrobial agent is used to 
describe any compound, naturally produced or chemically synthesized, which are inhibitory to 
microorganisms.  Antimicrobial agents are important tools in the fight against and elimination of 
infectious diseases (Hancock et al., 2005).  
Antimicrobial compounds are classified based on the following criteria: 
a. Chemistry and structure  
b. Spectrum of activity 
c. Mode of action of inhibition 
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a. Chemistry and Structure  
 Structurally, the antimicrobial compounds have simple to complex chemistry of purified and 
chemically modified compounds increase stability, solubility, or efficacy of naturally produced 
antibiotics compounds are synthetic, which are chemically synthesized (Table 1.1) 
Table 1.1 Classification of Antimicrobial Compounds based on the Chemistry and 
Structure 
Class of Compounds Chemistry and Structure Examples 
1. Aminocyclitols Amino polyhydroxy 
cycloalkanes. 
Spectinomycin 
   
2. Aminoglycosides Hexose nucleus to which amino 
sugar is linked by glycosidic 
bonds. 
Amikacin, Apramycin, 
Gentamicin, Kanamycin, 
Dihydrostreptomycin 
   
3. Bacitracin Polypeptide, consist of phenyl 
alanine, histidine, lysine and 
cystine  
 
   
4. Beta-lactams β-Lactam ring Amoxicillin, Ampicillin, 
Carbapenams, Ceftiofur, 
Cephalosporins, Cephalothin, 
Penicillins 
   
5. Diaminopyrimidines Two amine groups on a 
pyrimidine ring 
Trimethoprim 
   
6. Fluoroquinolones Addition of fluoride in the place 
of nitrogen in the position 6 to 
the quinolone molecule 
Enrofloxacin, Ciprofloxacin, 
Danafloxacin, Difloxacin, 
Marbofloxacin, Orbifloxacin  
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7. Lincosamides Proline residue, attached by a 
peptide bond to a galactoside 
ring 
Clindamycin, Lincomycin,  
   
8. Macrolides  12 – 16-member macro cyclic 
lactone ring connected to two or 
more sugar molecules 
Azithromycin, Clarithromycin, 
Erythromycin, Tilmicosin, 
Tildipirosin, Tulathromycin, 
Tylosin 
   
9. Nitroimidazoles Heterocyclic compounds with a 
five-membered nucleus  
Dimetronidazole, Ipronidazole, 
Metronidazole, Ronidazole, 
Tinidazole 
   
10. Phenicols  Derivatives of dichloroacetic acid 
and contain a nitrobenzene moiety 
Chloramphenicol, Florfenicol 
   
11. Pleuromutilins  Derivatives of naturally 
occurring diterpene antibiotic 
pleuromutilin  
Tiamulin  
   
12. Polymyxin  Polypeptide  Polymyxins B 
   
13. Rifamycins  Structurally related to 
Macrolides 
Rifampin, Novobiocin  
   
14. Sulfonamides  Sulfonamide group, structurally 
analogous to p-aminobenzoic 
acid 
Sulfamethoxazole, Sulfadiazine 
Sulfachlorpyridazin, 
Sulfamethazine, 
Sulfaquinoxaline 
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15. Tetracyclines Naphthacene ring with 
hydrochloride 
Chlortetracycline, Doxycycline, 
Minocycline, Oxytetracycline, 
Tetracycline 
   
16. Vancomycin Glycopeptide Vancomycin 
 
b. Spectrum Activity of Antimicrobial Compounds 
Broad-spectrum antimicrobial compounds are effective against gram-negative and gram-
positive bacteria, and tend to have higher toxicity to the recipient, such as tetracyclines.  Narrow- 
Table 1.2. Spectrum of Activity of Common Antimicrobial Compounds 
Antibiotics  Gram-
positive 
bacteria 
Gram- 
negative 
bacteria 
Mycoplasma Rickettsia Chlamydia 
Aminocyclitols 
 
- + - - - 
Aminoglycosides 
 
- + - - - 
Beta-Lactams 
 
+ - - - - 
Fluoroquinolones 
 
+ + + + + 
Lincosamides 
 
+ - + - - 
Macrolides 
 
+ - + - + 
Phenicols 
 
+ + + + + 
Pleuromutilins 
 
+ - + - + 
Tetracyclines 
 
+ + + + + 
Sulfonamides 
 
- + + - + 
Diaminopyrimidines 
 
+ - - - - 
spectrum drugs are effective against a limited group of microbes and exhibit lower toxicity to the 
recipient, such as penicillin (Table 1.2) 
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c. Mode of Action of Antimicrobial Compounds 
Antimicrobial agents work in two ways, by either killing the bacteria, which is called 
bactericidal, or by the preventing of the growth, which is called bacteriostatic.  The important 
targets for antimicrobial agents in the cell are the cell wall, cytoplasmic membrane, nucleic acids  
(DNA to RNA or DNA to RNA), and ribosomes (protein synthesis).  Antimicrobial compounds 
have four major modes of action: 
1. Inhibition of cell wall synthesis 
According to this mechanism of action, the synthesis of peptidoglycan, present in the cell 
wall of all bacteria, except Mycoplasma (Holtje et al., 1998), is inhibited.  The peptidoglycan 
structure is basically the same in both Gram-positive and Gram-negative organisms.  However, 
there are important differences.  Gram-negative bacteria have a thin peptidoglycan layer, which 
in loosely cross-linked.  Gram-positive bacteria, on the other hand, possess a very thick 
peptidoglycan layer.  Penicillins, cephalosporins, carbapenems, bacitracin and vencomycin are 
the antimicrobial compounds that prevent the synthesis of peptidoglycan (Park and Uehara, 
2008; Figure 1.1). 
2. Inhibition of protein synthesis 
Some antibiotics inhibit the process of protein synthesis by interfering with the ribosome.  
Bacteria have 70S ribosome, which consist of 50S and 30S subunits, whereas eukaryotic cells 
(animal or human cells) have 80S ribosomes, which make bacterial ribosome as a suitable target 
for selective inhibition.  Drugs that inhibit the protein synthesis are among the broadest classes of 
antibiotics, and can be divided into two subclasses; the 50S ribosome inhibitors and 30S 
ribosome inhibitors (Nissan et al., 2000).  The classes of antibiotics that inhibit protein synthesis 
are tetracyclines, macrolides, aminoglycosides, lincosamides, and chloramphenicol (Table1.3). 
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3. Disruption of the Cytoplasmic Membrane 
 These antimicrobials have an effect on the external membrane of Gram-negative bacteria.  
The compounds interact with phospholipids of the cell membranes, and disrupt the structure and 
function (Gilleland et al., 1984).  The end result is leakage of cytoplasmic contents and death of 
the cell.  Polymyxin, produced from Bacillus polymyxa, is an example for this mode of action.  
They are cyclic decapeptides, and they act like detergents, hence react with phospholipids of cell 
membranes and disrupt their integrity (Figure 1.1). 
Table 1.3. Classification of antimicrobial compounds based on mode of action 
Mode of action Mechanism Examples 
Interference with 
cell wall synthesis 
 
Prevent the synthesis of peptidoglycan, and the 
cell wall became weakened and the cell 
undergoes lysis 
β-Lactams 
Carbapenems, 
Cephalosporins 
Monobactams, 
Penicillins 
Glycopeptides 
Bacitracin, Isoniazid, 
Teicoplanin 
Vancomycin 
 
Interference with 
protein synthesis 
inhibition 
 
Bind to 50S ribosomal subunit Chloramphenicol, 
Clindamycin, Linezolid, 
Macrolides, 
Quinopristin-
Dalfopristin 
 Bind to 30Sribosomal subunit Aminoglycosides, 
Tetracyclines 
Disruption of 
bacterial membrane 
structure 
React with phospholipids of the cell membranes 
and disrupt their integrity 
Daptomycin, 
Polymyxins 
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Interference with 
nucleic acids 
 
Inhibit DNA synthesis: Fluoroquinolones, 
Novobiocin 
 Inhibit RNA synthesis: Rifamycins 
Interference in 
metabolic pathway 
Block folic acid synthesis Sulfonamides, 
Diaminopyrimidines 
Adapted from Tenover, 2006. 
Figure 1.1 The mechanism of action of antimicrobial on bacteria 
 
  
  
8 
 
 
4. Interference with Nucleic Acids 
DNA is the main storage form of genetic information in living organisms.  It is composed of 
two strands of nucleotides connected through a backbone of sugar and phosphates.  When the 
cells divide, DNA is replicated to produce new identical DNA copies that are incorporated into 
the new cells.  DNA is also transcribed to nucleic acid, messenger RNA, which directs the 
synthesis of proteins.  There are many enzymes that participate in the synthesis of nucleic acids 
that are potential therapeutic targets including DNA gyrase, and topoisomerase IV.  The 
differences between the enzymes used to synthesize nucleic acids in prokaryotes and eukaryotes, 
allow for selective action of antibiotics against prokaryotes by inhibiting nucleic acid synthesis.  
The rifamycin family prevents RNA synthesis and the reason is they bind to RNA polymerase, 
which is responsible for transcribing bacterial DNA to RNA.  Quinolone group works by 
inhibiting DNA gyrase.  DNA gyrase is responsible for DNA supercoiling, an important step in 
the process of DNA replication (Kohanski et al., 2010).  These groups of antibiotics have the 
ability to enter the tissues and reach appropriate level to have an effect.  The process involves 
numerous enzymes and other proteins because enzymes are selectively targeted from specific 
organisms.  Therefore, in human medicine it is used to treat tuberculosis, and even leprosy.  
However, resistance develops rapidly and hence not often used alone (Kohanski et al., 2010).  In 
animals, it is used in combination with a macrolide, such as erythromycin, clarithromycin, to 
treat Rhodococcus equi infection that cause pneumonia in horses and Potomac Horse Fever 
caused by Neorickettsia risticii.  Some antimicrobial drugs can interfere with the termination of 
RNA transcription.  The antibiotics that inhibit nucleic acid include rifamycins, novobiocin, 
quinolones and fluoroquinolones, and nitroimidazoles (Gilleland et al., 1984).   
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5. Interference in metabolic pathways 
Para Amino Benzoic Acid (PABA) is key to mechanism of sulfonamide action.  The bacteria 
that are sensitive to sulfonamides need para amino benzoic acid for the growth.  Sulfonamides or 
sulfa drugs are structurally analogous to p-amino benzoic acid, which is a part of the vitamin 
folic acid, a precursor in the synthesis of nucleic acids.  Sulfa drugs mainly inhibit the process of 
folic acid synthesis in bacteria by competing with p-amino benzoic acid for the enzyme 
dihydropteroate synthetase.  The mammalian cells do not synthesize folic acid, but the bacteria 
synthesis their folic acid when growing in the host, and sulfa drugs are effective only against 
bacterial cells.  Sulfa drugs have broad-spectrum activity including effects on protozoa such as 
coccidia and are bacteriostatic.  The sulfonamides and trimethoprim are known to inhibit folate 
biosynthesis in bacteria, and they are widely clinically used drugs (Holtje et al., 1998); Figure 
1.2) 
Figure 1.2 Inhibition of folic acid synthesis 
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Use of Antimicrobial compounds in animals 
Antimicrobial compounds are used in animals to treat and control infectious diseases, and for 
growth promotion.  If we protect the health of animals, then we protect human health as well.  
This is because 60% of diseases that affect humans come from animals, and the relationship 
between the animal health and human health is very strong (Karesh et al., 2012).  In the United 
States, the yearly overall production of antibiotics in 1979 was 17.5 million Kg.  Of those, 12.5 
million Kg are used for non-therapeutic purposes in livestock production, and only 1.5 million 
Kg are used for human medical treatments (Mellon et al., 1979).  Food and Drug Administration 
(FDA) has approved the use of some antimicrobials for the promotion of growth in certain 
livestock, and poultry (Table 1.4). The most important uses of antibiotics in animals are to treat 
bacterial infections and to promote animal growth.  In the absence of preventive treatments, the 
infections would occur more frequently and would require more therapeutic interventions 
(Schwarz et al., 2001).  In the USA and Canada, agricultural use of antibiotics is regulated, and 
there are three ways of use: as feed antibiotics, as over the-counter drugs, and as veterinary 
prescription drugs.  Feed antibiotics include antibiotics used for growth promotion and those 
used for sub therapeutic (including prophylactic, and some growth-promotion use), and 
therapeutic purposes (Prescott, 1993).  Antimicrobial agents are commonly used in animals for 
the following purposes: 
a) Therapy: Treatment of bacterial infections  
b) Prophylaxis: Treatment of the healthy animals to prevent the onset of diseases 
c) Metaphylaxis: Treatment of all animals in a herd after one or two show clinical signs.  
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d) Growth promotion: Inclusion antimicrobial agents in the feed to improve the growth. 
 
 
Table 1.4 Antimicrobial Agents approved for use in livestock in the US 
Antibiotic class Example Species  Used in feed 
 
Beta-lactams Amoxicillin Beef, Dairy cattle, Poultry, Swine No 
 Ampicillin Beef, Dairy cattle, Poultry, Swine No 
 Penicillin Beef, Dairy cattle, Poultry, Swine No 
    
Aminocyclitol Spectinomycin Beef, Dairy cattle, Poultry, Swine No 
    
Aminoglycoside Apramycin Swine Yes 
 Gentamicin Beef, Dairy cattle, Poultry, Swine No 
 Hygromycin Poultry, Swine Yes 
 Neomycin Beef, Dairy cattle, Poultry, Swine Yes 
    
Bacitracin Bacitracin Beef, Dairy cattle, Poultry, Swine Yes 
    
Bambermycin Bambermycin Beef, Dairy cattle, Poultry, Swine Yes 
    
Cephalosporin Ceftiofur Beef, Dairy cattle, Poultry, Swine No 
    
Diterpene Tiamulin Swine Yes 
    
Fluoroquinolone
s 
Enrofloxacin Beef No 
 Danofloxacin Dairy cattle No 
    
Lincosamines Lincomycin Beef, Dairy cattle, Poultry, Swine Yes 
 Pirlimycin Beef, Dairy cattle No 
    
Macrolides Erythromycin Beef, Dairy cattle, Poultry, Swine No 
 Oleandomycin Beef, Dairy cattle No 
 Tilmicosin Poultry, Swine Yes 
 Tylosin Beef, Dairy cattle, Poultry, Swine Yes 
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Novobiocin Novobiocin Beef, Dairy cattle, Poultry Yes 
    
Orthosomycin Avilamycin Swine Yes 
    
Phenicols Florfenicol Beef, Dairy cattle, Poultry No 
    
Polypeptides Colistin Poultry Yes 
 Polymyxin Beef, Dairy cattle Yes 
    
Quinoxaline Carbadox Poultry, Swine Yes 
    
Streptogramins Virginiamycin Poultry, Swine Yes 
    
Sulfonamides Sulfachlorpyridizine Beef, Dairy cattle, Swine No 
 Sulfadimethoxine Beef, Dairy cattle, Poultry, Swine No 
 Sulfamethazine Beef, Dairy cattle, Poultry, Swine Yes 
 Sulfaethoxypyridazi
n 
Beef, Dairy cattle, Poultry, Swine No 
 Sulfathiazole Beef, Dairy cattle, Swine Yes 
    
Tetracyclines Chlortetracycline Beef, Dairy cattle, Poultry, Swine Yes 
 Oxytetracycline Beef, Dairy cattle, Poultry, Swine Yes 
 Tetracycline Beef, Dairy cattle, Poultry, Swine No 
(Adapted from Mathew et al., 2007) 
Mechanisms of Antimicrobial Resistance 
Bacteria may gain resistance to antibacterial agents via a variety of mechanisms.  Some 
species of bacteria are innately resistant to more than one class of antimicrobial agents.  In such 
cases, all strains of that bacterial species are resistant to all the members of that antibacterial 
class.  For example, Mycoplasma is resistant to penicillins because they do not have cell wall.   
There are many cases of acquired resistance, where initially susceptible populations of bacteria 
become resistant to an antimicrobial agent, and proliferate and spread under the selective 
pressure of use of those antimicrobial agents.  There are a variety of mechanisms of acquired 
antimicrobial drug resistance and they are: 
a) Change in the target inside the cell so that it will not bind to the antibiotic. 
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Example: Change in the penicillin binding protein in pneumococci, which can confer 
resistance to penicillin. 
b) The organisms may destroy the antibacterial agent before it can have an effect by acquiring 
genes that encode for the enzymes. 
Example:  -lactamases, erythromycin ribosomal methylase in staphylococci. 
c) Bacteria may acquire efflux pumps that extrude the antimicrobial agent from the cell before it 
can reach its target site and exert its effect.  These pumps are present in the cytoplasmic 
membrane of Gram-negative and Gram-positive bacteria.  Some are single component pumps 
and the other multicomponent pumps. 
Example: efflux of fluoroquinolones in Staphylococcus aureus (McManus, 1997). 
d) Biochemical pathway some bacteria may become resistant by the changing of their 
metabolism by altering biochemical pathway.  
Example: Sulfonamides inhibit the production of folic acid synthesis (Tenover, 2006).   
Normally, susceptible populations of bacteria may become resistant to antimicrobial agents 
via mutation as well as selection, or via gaining the genetic information that encodes resistance 
from other microbes, called horizontal gene transfer.  The gene transfer may occur via one of 
three genetic mechanisms, transformation, conjugation, or transduction.  Because of genetic 
exchange, many bacteria can become resistant to multiple classes of antibacterial agents, and 
these multidrug resistance bacteria are of serious concern (McManus, 1997). 
Horizontal Gene Transfer 
The spread of antimicrobial resistance within species or different species of bacteria is 
basically the outcome of horizontal gene transfer, a phenomenon of mobile genetic elements that 
carry the resistance genes from one organism to the other.  The transmission of antimicrobial 
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resistance genes from mother cell to daughter cells is called vertical gene transfer.  It is difficult 
to account for modification, inactivation, or differential regulation of the genes by mutations 
alone (Narra and Ochman, 2006).  The bacteria reproduce by binary fission, which result in the 
genetic replication of one bacterial cell into two daughter cells.  The result of this type of 
reproduction is producing identical bacterial cells genetically and both have same susceptibilities 
to environmental pressures like antimicrobial compounds.  These are three main classes of 
horizontal gene transfer, and they are: transformation, transduction and conjugation (Figure 1.3) 
 
1. Transformation 
The genetic variation will be increased via transformation method between the competent 
bacteria that take the DNA from the surrounding environment and using it into the genetic 
material of the recipient to complete its cellular functions.  It was first noticed in 1928 by  
Figure 1.3 Horizontal gene transfer
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Fredrick Griffith, who reported that a strain of Streptococcus pneumoniae had two different 
phenotypes and had different effects on mice (Griffith, 1928).  The initial conditions for the 
natural transformation include the release of extracellular DNA in the environment, and 
capturing of the free DNA by the donor cells.  The release of DNA from dead bacteria occurs 
after self-induced lysis, which results in broken cell walls and membranes and the release of the 
cell contents, including DNA, into the environment (Palmen and Hellingwerf, 1995; Schwarz et 
al., 2001).  The free DNA comes from the lysed bacterial cells, which are degraded under most 
environmental conditions.  However, few bacteria, such as S. pneumoniae or Bacillus spp, have 
the natural ability to take up DNA from the surrounding environment.  A restriction of 
transformation is that not all bacteria in a population will uptake DNA, be able to take in 
sufficient amounts of gene needed for survival, or the required gene may not be in the immediate 
environment of bacteria (Lorenz and Wackernagel, 1994).  
2. Transduction 
Transduction process is mediated by bacteriophages.  Bacteriophages are bacterial viruses, 
and are capable of transferring the DNA into new recipient cells.  Transduction has been shown 
to be responsible for the mobility of Shiga toxin genes (stx1 and stx2) from Shigella species to 
the virulent E. coli O157:H7 (Plunkett et al., 1999).  The restriction of transduction is similar to 
transformation, as it is relies on the required gene to be present and taken up by the proper phage 
at the perfect time, and the donor and the recipient must be sensitive to the same bacteriophage 
(Lorenz and Wackernagel, 1994; Muniesa and Jofre, 2004). 
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3. Conjugation 
Conjugation is transfer of an antimicrobial resistance gene via conjugative plasmid or 
transposon from a donor cell to a recipient cell.  This is the most important method of horizontal 
transfer of antimicrobial resistance gene in bacteria.  It has been shown to be important for the 
promotion of the survival and evolution of many bacterial species.  Close contact between donor 
cells and recipient cells is one of the major requirements for the conjugation process; it is 
performed by horizontally transferring genetic elements that was packaged in plasmids or 
transposons into the cytoplasm for the passage into the recipient cell (Narra and Ochman, 2006).  
These transposons and plasmids increase the high efficiency transfer of antimicrobial and 
virulence genes from single resistant donor bacterium to many recipient bacterial cells, and the 
outcome is the donation of the resistance genes to several recipient bacterial cells (Thomas and 
Nielsen, 2005).  Horizontal transfer by conjugation method is not exclusive to the bacteria of the 
same species, but it can be performed between different species.  Also, the conjugative 
horizontal transfer is not exclusive to bacterial species, because there are studies that have shown 
transfer of genetic materials between bacteria and yeasts, and between bacteria and plant cells, 
and also between the bacteria and the mammalian cells (Rosenberg et al., 1998; Vicky, 1987).  
The transfer by conjugation between the bacteria that carry antimicrobial resistance genes has 
very high impact on human and animal health (van den Eede et al., 2004). 
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Chapter 2 - Norepinephrine on Conjugation of Escherichia Coli 
Norepinephrine and Bactria  
 Catecholamines are a group of hormones that include epinephrine (adrenaline), 
norepinephrine (NE; noradrenaline) and dopamine.  Norepinephrine is produced in the body  
Figure 2.1 Noradrenaline Synthesis 
from tyrosine (Figure 2.1), released 
from the adrenal medulla into the 
blood, and it is also a neurotransmitter 
in the central and sympathetic 
nervous systems, where it is released 
from noradrenergic neurons.  The 
epinephrine and NE hormones are the 
sympathetic neuroendocrine mediators of fight or flight (acute stress) response of the host.  The 
elevated catecholamine levels make the blood more prone to clotting, thus reducing the risk of 
heavy bleeding in case of tissue damage (Karasek et al., 1982; Krantz and Manuck, 1984).  
However, high catecholamine level increases the risk of arterial obstruction and myocardial 
infarction (Rozanski et al., 1988; Yusuf et al., 2004).  More than half of the NE hormone is 
synthesized and utilized in the enteric nervous system (Furness, 2000).  It is estimated that the 
physiological concentration of NE in the gastrointestinal tract is as high as 50 μM (Thomas, and 
Nielsen. 2005).  The human and animals gastrointestinal tracts particularly the rumen in 
ruminants and hindgut in monogastrics and ruminants, are inhabited by a dense population of 
bacteria (10
11
/g - 10
12
/g of contents), whose composition is influenced by the health of the host.  
The gut flora has evolved specific system to detect or sense neuroendocrine secretions, and use 
Tyrosine 
Tyrosine hydroxylase 
3, 4-dihydroxyphenylalanine (DOPA) 
Aromatic L-amino acid 
decarboxylase 
Dopamine 
Dopamine  -hydroxylase 
Noradrenaline 
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such mediators as environmental cues to alter their growth and virulence.  A serum-based iron-
depleted medium showed that catecholamines increased the growth of bacteria (Lyte, and Ernst. 
1992), which was initially assumed to be due to enhanced iron acquisition through the use of 
catecholate-specific iron transport system (Bearson et al., 2008; Freestone et al., 2000).  
Additional studies have shown that catecholamines can influence the production of virulence 
factors, such as toxins, adhesins, biofilm formation, and quorum sensing molecules, even under 
conditions where iron was not a limiting factor (Lyte et al., 1996; Reading and Sperandio, 2006).  
For example, E. coli O157 when exposed to catecholamines will respond by increasing the 
expression of Shiga toxins (Dowd, 2007), increasing adherence to eukaryotic cells (Chen et al., 
2003), promoting attachment and effacement (A/E) lesions (Reading and Sperandio, 2006), and 
increasing flagella expression and motility (Clarke et al., 2005).  Catecholamines have also been 
shown to stimulate motility and promote colonization of Salmonella in the gut of swine.  This 
observation provides a non-immunological interpretation for increased incidence and severity of 
infectious diseases during the period of stress.  Peterson et al., (2011) have reported that 
norepinephrine at physiological concentrations increase the horizontal gene transfer efficiency of 
a conjugative plasmid from a donor, Salmonella typhimurium, to a recipient, E. coli in vitro.  The 
mechanism of the effects of catecholamines on horizontal gene transfer in bacteria is presently 
not known (Peterson et al, 2011).  
 
Escherichia coli  
Escherichia coli are Gram-negative bacteria and the species is a member of the 
Enterobacteriaceae family.  Escherichia coli occurs widely in nature, including the intestinal 
tracts of humans, animals and other vertebrates, such as birds and reptiles.  Most E. coli does not 
cause illnesses.  However, there are few types that can cause infections in animals and people.  
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These types of E. coli that cause diseases are classified based on the patterns of attachment on 
recipient, the types toxins produced, and invasiveness. 
1. Enterotoxigenic (ETEC)  
 Enterotoxigenic E. coli, known as Cholera-like, is the most common cause of E. coli diarrhea 
in farm animals.  This type of E. coli is characterized by the production of enterotoxins.  The 
enterotoxin that is produced may be a heat stable (100 °C for 15 min), or heat labile (60 °C
 
for 15 
min).  Also, it does not cause histological changes or invade the enterocytes.  The attachment is 
mediated by pili.  
 
2. Attaching and Effacing (AEEC), Enterohemorrhagic (EHEC), Shiga toxigenic E. coli 
(STEC), or Verotoxigenic (VTEC) 
Biologically and structurally, the toxin produced by this type resembles the cytotoxin of 
Shigella dysenteriae, which is why they are called Shiga toxin.  The type also invades the tissues.  
The toxins are heat labile and lethal for cultured Vero cells, which is why they are called 
Verotoxins.  They are chemically proteins and have A and B subunits.  The subunit A has 
cytotoxic activity, and B subunit has the binding function.  There are two types of shiga toxins.  
Shiga toxin 1 is identical to shiga toxin of Shigella dysenteriae, and shiga toxin 2 has 56% 
homology to shiga toxin 1. 
 
3. Enteroinvasive (EIEC) 
This type is referred to as Salmonella-like.  It invades the tissues and destroys the cells, and 
may be able to multiply inside living cells (facultative intracellular pathogen).  It causes 
bacteremia or septicemia, mostly seen in poultry.  The strains are rarely found in mammals. 
 
  
22 
4. Enteropathogenic (EPEC) 
 This type causes diarrhea in many animals, most often in pigs, rabbits, and dogs.  The 
attachment is mediated by pili and it causes loss of microvilli (effacement).  It dose not 
produce Shiga toxins (verotoxins) or enterotoxins.  The main virulence factors are pili and 
cytotoxin. 
 
5. Enteroaggregative (EAggEC) 
 This group tends to clump in small aggregates, both in vitro and in vivo.  The clumping is 
because of thin fibrillar structures, pili.  They do not invade the small intestinal cells, but they 
bind to them.  They cause a persistent form of diarrhea in children.  This type produces ST-like 
toxin called EAST (heat stable enterotoxin for Enteroaggregative) and hemolysin-like toxin. 
 
Norepinephrine and E. coli 
 There are several highly adapted E. coli strains that have acquired specific virulence 
attributes, which confer an increased ability to adapt to new niches and allow them to cause a 
variety of diseases (Stins et al., 1999).  The prevalence of bacteria resistant to antimicrobial 
compounds within animal and human population complicates infection control (Stins et al., 
1999).  The growth-stimulating effect of catecholamines was assumed to be the result of 
increased iron acquisition and consumption through catecholate-specific iron carrying system 
with participation of enterobactin and enterochelin ways (Bearson et al., 2008).  The growth and 
virulence of many Gram-negative and Gram-positive bacteria has been stimulated by 
catecholamines.  Bacteria respond to the increase of concentrations of stress hormones by 
increasing the growth and promoting the possibility to cause disease, which leads to an increased 
transmission to a new healthy host (Freestone et al., 2008).  Studies have been confirmed that 
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catecholamines can have an effects on the production of virulence factors like adhesins, toxins, 
biofilm development, and quorum sensing, even in iron-replete circumstances (Lyte and Ernst, 
1992; Sperandio et al., 2002).  Dowd et al., (2007) have reported that Escherichia coli O157 
responds to catecholamines by increasing the expression of shiga toxins.  On the small intestinal 
epithelium, norepinephrine increases the growth of enterotoxigenic E. coli, and its expression of 
F5 fimbrial adhesin, which mediates the attachment of the bacterium to epithelial receptors (Lyte 
et al., 1997; Nagy and Fekete, 2005).  Peterson et al., (2011) have reported that norepinephrine at 
normal concentrations increased the horizontal gene transfer efficiency of a conjugative plasmid 
from Salmonella Typhimurium to Escherichia coli in vitro.  Also, they observed an upregulation 
of the expressions of plasmid encoded transfer genes, which are necessary for conjugation in the 
presence of NE. 
 
Effects of Norepinephrine on Conjugation in E. coli 
 The pathogenic bacteria have the ability to sense as well as respond to the stress in the host. 
The epinephrine and norepinephrine play a key role in stress situations in animals.  The 
horizontal gene transfer is an important mechanism that contributes to bacterial diversity.  
Transformation is one mechanism that involves the uptake of the free DNA from the 
environment and has the potential to transmit DNA between far related organisms (Chen and 
Dubnau, 2004).  The genetic material also can be introduced into a bacterium by a bacteriophage 
that has replicated into the donor organism and packaged random DNA fragments, or the DNA 
adjacent to the phage attachment site (Ochman et al., 2000).  Conjugation is mechanism that 
involves physical contact between donor and recipient cells and can mediate the transfer of 
genetic material between microorganisms (Ochman et al., 2000).  Peterson et al., (2011) have 
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shown that NE at physiological concentrations enhanced horizontal gene transfer efficiencies of 
a conjugative plasmid from a strain of Salmonella Typhimurium to an E. coli in vitro. 
 
Objective of the Experiment 
The primary objective was to determine the effect of norepinephrine on conjugation between 
two E. coli strains.  The effects of norepinephrine were tested at two concentrations, 5 mM and 
20 mM.  Escherichia coli FS1290 was as the donor and strain C600N was the recipient in the 
conjugation assay.  Both filter mating and liquid mating assays were performed. 
 
Materials and Methods 
 Bacterial strains and culture medium:  The bacterial strain used in this experiment was E. 
coli FS1290 with a conjugative self-transmissible plasmid.  This plasmid is 64-kb in size and 
carries genes that confer resistance to ampicillin, tetracycline, streptomycin and kanamycin 
(Table 2.1).  The recipient E. coli C600N has a chromosomal mutation that confers resistance to 
nalidixic acid (Table 2.2).  Strains were grown at 37° C in Luria Bertani broth (LB; Franklin 
Lakes, NJ. USA). 
Norepinephrine medium.  Stock solution (50 mg/ml in 0.5 M HCl) of NE (Sigma-Aldrich, 
St Louis, MO) was prepared.  Further dilutions to achieve 5 mM and 20 mM of NE were 
performed in LB broth and mixed with media for plating.  All procedures (preparation of the 
solution, dilution, and plating) were done in the dark.   
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Table 2.1 Escherichia coli FS1290 genotype 
Mutation Location Certainty Display 
Lac-3350 7.77 1 lac-3350 
galK2(Oc) 16.99 1 galK2(Oc) 
galT22 17.01 1 galT22 
LAM- 17.40 1 λ
- 
 
IN(rrnD-rrnE)1 73.74 1 IN(rnnD-rnnE)1 
rpsL179(strR) 74.84 1 rpsL179(strR) 
DeoA21 99.50 1 deoA21 
The resource of these data is Coil Genetic Stock Center, available on http://cgsc.biology.yale.edu/Strain.php?ID=122766 
 
 Table 2.2 Escherichia coli C600N genotype 
Mutation Location Certainty Display 
Thr-1 0.01 1 thr-1 
leuB6(Am) 1.74 1  leuB6(Am) 
 
fhuA21 3.61 1 fhuA21 
Cyn-101 7.72 0 cyn-101 
LacY1 7.79 1 lacY1 
glnV44(AS) 14.99 1 
 
glnV44(AS) 
 
LAM- 17.40 1 λ
-
 
rfbC1 45.43 1 rfbC1 
GlpR200(glp$^c$) 76.68 1 glpR200(glp
c
) 
thiE1 90.34 1 thiE1 
The resource of these data is Coil Genetic Stock Center, available on   http://cgsc.biology.yale.edu/Strain.php?ID=11195 
 
 Conjugation by filter mating 
 Strains FS1290 and C600N were streaked on Luria Bertani (LB) agar plates containing 
appropriate antibiotics and individual colonies were picked to check for purity.  Strain FS1290 
was grown on LB agar containing ampicillin at 50 µg/mL and strain C600N was grown on LB 
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agar containing 12.5 µg/mL of nalidixic acid.  Strains were inoculated separately in to tubes of 
LB broth with 50 µg/mL ampicillin for FS1290 or 12.5 µg/mL nalidixic acid for C600N and 
incubated at 37° C in shaking incubator overnight (16 hours).  Five mL LB broth in a 15 mL-
tube was inoculated with FS1290 (donor) by using a sterile loop.  In another 15-mL tube, 5 mL 
of LB broth was inoculated with E. coli C600N (recipient).  Broths were incubated at 37° C in a 
shaking incubator overnight (16 hours).  Overnight cultures were diluted in pre-warmed LB 
broth (1 mL overnight culture + 5 mL pre-warmed LB broth) and incubated for 1.5 hours until 
they reached a turbidity of 0.3 at 600 nm (Spectronic 20D
+
 Milton Roy, Warminster, PA).  One 
mL of donor culture and 5 mL of recipient culture were run through a filter-mating unit 
(Millipore Filter Corp) and the filter was placed on LB agar plate containing 20 mM NE.  
Another filter containing mixture was placed on LB agar plate without NE (control) and 
incubated for 16 hours (Table 2.3) 
Serial dilutions.  Each membrane was taken from the plates and placed in 50 ml tube 
containing 5 mL LB broth and vortexed.  Ten-fold dilutions were carried out in LB broth by 
mixing 100 µL from the culture + 900 µL of plain LB.  Fifty µL of each dilution (10
-1
 – 10-10) 
were plated on LB agar with selected antibiotics; LB agar + tetracycline (10 µg/mL), or LB agar 
+ streptomycin (50 µg/mL) for FS1290, LB agar + nalidixic acid (12.5 µg/mL) for C600N, and 
LB agar containing tetracycline (10 µg/mL) + nalidixic acid (12.5 µg/mL) for transconjugant and 
incubated overnight (figure 2.2). 
Counting the colonies.  After the incubation period hours, plates that had colonies between 
20 and 200 were counted to determine conjugation ratio (transconjugant/donor, and 
transconjugant/recipient).  
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 Conjugation by liquid mating 
Overnight cultures and media preparations were same as described before.  The liquid mating 
protocol was the donor + recipient were diluted at 1:5 ratio and incubated in liquid medium for 4, 
6, 8, or 16 hours (Table 2.4) 
Figure 2.2 Illustration of the experiment sequence 
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Polymerase chain reaction (PCR):  A PCR assay was carried out to determine if the plasmid 
was transferred from FS1290 (donor) to the transconjugant.  Ten randomly picked 
transconjugant from LB agar plates containing tetracycline and nalidixic acid were tested.  The 
primers that were used in the PCR assay were: MA-ApRF and the sequence was 5-TTG CCG 
GGA AGC TAG AGT AA -3, the other primer was MA-ApRR and the sequence was 5-GCT 
ATG AGG CGC GGT ATT AT -3.  The primers were obtained from Integrated DNA 
Technologies (IDT, Coralville, IA). 
 
Statistics. Graph Pad prism 5.03 was used to analyze the data.  One-way ANOVA with posttest 
using Dunns multiple comparison tests were, used for all analysis. 
 
Results 
Filter mating assay 
Effect of 5 mM NE on conjugation.  This experiment was done one time, and in the 
absence of NE, the count of the donor was 1.5 x 10
8
 CFU/mL, and the count of the recipient was 
3.4 x 10
8 
CFU/mL, and count of the transconjugant was 1.9 x 10
8 
CFU/mL.  In the presence of 
NE, the donor count was 6.4 x 10
8 
CFU/mL with count of recipient 7.8 x 10
8 
CFU/mL, and 
transconjugant was 7.0 x 10
8 
CFU/mL (Figure 2.3). 
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Figure 2.3 Effect of 5 mM norepinephrine on conjugation in filter mating assay with 4 
hours of incubation  
 
 Effect of 20 mM NE on conjugation. This experiment was done three times.  Results 
from individual experiments and the mean are presented (Figures 2.4, 2.5, 2.6 and 2.7).  In 
the absence of NE, the mean count of the donor was 2.7 x 10
8
 CFU/mL (Log 8.4 CFU/mL), and 
the mean count of the recipient was 4.0 x 10
8 
CFU/mL (Log 8.6 CFU/mL), and mean count of 
the transconjugant was 2.6 x 10
7 
CFU/mL (Log 7.4 CFU/mL).  In the presence of NE, the 
average of donor was 4.0 x 10
9 
CFU/mL (Log 9.6 CFU/mL), with average of recipient 5.2 x 10
9 
CFU/mL (Log 9.7 CFU/mL),, and transconjugant was 5 x 10
7 
CFU/mL (Log 7.6 CFU/mL).  The 
P-value for donor vs donor +NE was 0.73.  The P-value for recipient vs recipient + NE was 0.82 
The P-value of transconjugant vs transconjugant + NE was 0.87.  
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Figure 2.4 Effect of 20 mM norepinephrine on conjugation in filter mating assay with 4 
hours of incubation (Expt.1) 
 
 
 
Figure 2.5 Effect of 20 mM norepinephrine on conjugation in filter mating assay with 4 
hours of incubation (Expt.2) 
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Figure 2.6 Effect of 20 mM norepinephrine on conjugation in filter mating assay with 4 
hours of incubation (Expt. 3) 
 
 
Figure 2.7 Effect of 20 mM norepinephrine on conjugation in filter mating assay with 4 
hours of incubation (mean of three experiment) 
 
Liquid mating assay 
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Effect of 5 mM NE on conjugation with 4 hours incubation. In the absence of NE, the 
mean count of donor was 3.6 x 10
8 
CFU/mL (Log 8.7 CFU/mL), and the mean count of the 
recipient 4.4 x10
8 
CFU/mL (Log 8.0 CFU/mL), but no growth for transconjugant.  In the 
presence of NE, the mean count of donor was 4.2 x 10
7 
CFU/mL (Log 8.6 CFU/mL), and the 
mean count of recipient was 2.6 x 10
8 
CFU/mL (Log 8.1 CFU/mL), and the mean count of 
transconjugant was 5.2 x 10
4 
CFU/mL (Log 4.7 CFU/mL).  The P-value for donor vs donor +NE 
was P = 0.9 which is more than P = 0.05 so there is no significant difference.  P-value for 
recipient vs recipient +NE was P = 1.0 which was more than P = 0.05, so there was no 
significant difference.  The P-value of transconjugant vs transconjugant +NE was 0.51 which is 
also more the P = 0.05 and there was no significant difference (Figures 2.8, 2.9, 2.10 and 2.11).  
 
Figure 2.8 Effect of 5 mM norepinephrine on conjugation in liquid mating assay with 4 
hours of incubation 
 
8.7 
8.0 
8.6 
8.1 
0 5 10 15
Donor
Recipient
Transconjugant
Donor + Norepinephrine
Recipient + Norepinephrine
Transconjugant  + Norepinephrine
Colony-forming Units/ml, Log10 
  
34 
 
Figure 2.9 Effect of 5 mM norepinephrine on conjugation in liquid mating assay with 4 
hours of incubation 
 
 
Figure 2.10 Effect of 5 mM norepinephrine on conjugation in liquid mating assay with 4 
hours of incubation 
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Figure 2.11 Effect of 5 mM norepinephrine on conjugation by liquid mating assay with 4 
hours of incubation (Mean of three experiments) 
 
 
 Effects of 5 mM NE in 6, 8, and 16 hours of incubation on conjugation.   In the absence 
of NE, the mean count of the donor was 5.5 x 10
7 
CFU/mL, and the mean count of recipient 2.9 
x10
7 
CFU/mL, and mean count of transconjugant 2.8 x 10
5 
CFU/mL.  In the presence of NE, the 
mean count of donor was 5.6 x 10
7
CFU/mL, and mean count of recipient 5.1 x 10
7 
CFU/mL, and 
mean count of transconjugant 5.3 x 10
4 
CFU/mL.  The
 
P-value for donor vs donor +NE was P = 
0.50 which is more than P = 0.05 there is no significant difference.  The P-value for recipient vs 
recipient +NE was P = 0.50, also it was more than P = 0.05, so there was no significant 
difference.  The P-value of transconjugant vs transconjugant +NE P-value was 0.67 which is also 
was more the P = 0.05 and there was no significant difference (Figures 2.12, 2.13 and 2.14). 
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Figure 2.12 Effect of 5 mM norepinephrine on conjugation in liquid mating assay with 6 
hours of incubation 
 
 
Figure 2.13 Effect of 5 mM norepinephrine on conjugation in liquid mating assay with 8 
hours of incubation 
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Figure 2.14 Effect of 5 mM norepinephrine on conjugation in liquid mating assay with 6 
hours of incubation 
 
Effect of 20 mM NE on conjugation incubation in liquid mating assay with 4 or 6 hours 
of incubation.  In the absence of NE and the mean count of donor 6.8 x 10
6 
CFU/ml, and the 
mean count of recipient 7.1 x 10
7 
CFU/ml, and mean count of transconjugant 4.5 x 10
4
CFU/ml.  
In the present of NE the mean count of donor 3.2 x 10
7
CFU/ml, and the mean count of recipient 
2.2 x 10
7 
CFU/ml, and mean count of transconjugant 5.6 x 10
4 
CFU/ml.  The
 
P-value for donor 
vs donor +NE was P = 0.81 which is more than P = 0.05 there is no significant difference.  P-
value for recipient vs recipient +NE was P = 0.05 which was less than P = 0.05, so there was a 
significant difference.  The P-value of transconjugant vs transconjugant +NE P-value was 0.7719 
which was more the P = 0.05 and there was no significant difference (Figures 2.15 and 2.16). 
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Figure 2.15 Effect of 20 mM norepinephrine on conjugation in liquid mating assay with 4 
hours of incubation 
 
 
 
Figure 2.16 Effect of 20 mM norepinephrine on conjugation in liquid mating assay with 6 
hours of incubation 
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Polymerase Chain Reaction  
The PCR assay showed that donor and transconjugant had the band, but there was no band 
with the recipient and the control (Figure 2.17) 
Figure 2.17 Gel image of the ampicillin resistant gene present in Escherichia coli strain 
FS1290 and the transconjugant and absent in E. coli strainC600N 
 
Conclusion 
In conclusion, norepinephrine did not have any significant effect on conjugation efficiency of 
plasmid between E. coli FS1290 and E. coli C600N.  Although, we did not use NE at many 
concentrations, we observed that NE at 5 mM and 20 mM concentration did not have any 
significant effect either in filter mating or liquid mating on conjugation. The transconjugant ratio 
is very high in our experiment making it difficult to evaluate augmentation of conjugation by 
 
Ladder        FS1290        C600N       Trans       Water 
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NE. Therefore, a plasmid system with lower efficiency of transfer may be employed in further 
studies.  The various incubation periods 4, 6, 8, 16 did not have any effect on efficiency of 
conjugation.  Further research is needed to elucidate more on the effects of norepinephrine on 
conjugation. Increasing the NE concentration more than 5 mM and 20 mM may improve the 
efficiency of conjugation.  
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Table 2.3 Effects of norepinephrine on Escherichia coli conjugation determined by filter mating assay. 
  No Norepinephrine  With Norepinephrine 
Experiment Incubation 
period 
Donor Recipient Transconjugant  Donor Recipient Transconjugant 
Norepinephrine, 5 mM 
Experiment 1 4 hours 1.5 x 10
8
 3.4 x 10
8
 1.9 x 10
8
  6.4 x 10
8
 7.8 x 10
8
 7.0 x 10
8
 
 
Norepinephrine, 20 mM 
Experiment 1 4 hours 4.0 x 10
9
 2.9 x 10
9
 1.2 x 10
9
  8.1 x 10
9
 3.4 x 10
10
 1.5 x 10
9
 
Experiment 2 4 hours 2.3 x 10
8
 2.8 x 10
8
 2.8 x 10
7
  1.9 x 10
8
 6.1 x 10
8
 6.7 x 10
6
 
Experiment 3 4 hours 1.9 x 10
8
 6.3 x 10
8
  3.8 x 10
7
  1.9 x 10
9
  6.1 x 10
8
 7.0 x 10
6
 
Mean 4 hours 2.7 x 10
8
 4.0 x 10
8
 2.6 x 10
7
  4.0 x 10
9
 5.2 x1 0
9
 5.0 x 10
7
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Table 2.4 Effects of norepinephrine on Escherichia coli conjugation determined by liquid mating assay 
  No Norepinephrine  With Norepinephrine 
Experiment Incubation 
period 
Donor Recipient Transconjugant  Donor Recipient Transconjugant 
Norepinephrine, 5 mM 
Experiment 1 4 hours 5.1 x 10
8
 1.1 x 10
8
  N/A  4.2 x 10
8
 1.4 x 10
8
  N/A 
Experiment 2 4 hours 3.8 x 108 8.7 x 108  N/A  6.0 x 107 3.2 x 108  N/A 
Experiment 3 4 hours 1.8 x 108 2.9 x 108  N/A  2.2 x 107 3.2 x 108 5.2 x 104 
Mean 4 hours 3.6 x 108 4.4 x 108 N/A  4.2 x 107 2.6 x 108 5.2 x 104 
 
Norepinephrine, 5 mM 
Experiment 1 6 hours 2.9 x 107 1.7 x 107 3.6 x 104  5.5 x 107 6.7 x 107 2.8 x 104 
Experiment 2 8 hours 3.6 x 107 4.4 x 107 N/A  6.9 x 106 4.3 x 107 3.4 x 104 
Experiment 3 16 hours 9.9 x 107 2.7 x 108 2.0 x 106  4.1 x 107 4.3 x 107 9.7 x 105 
 
Norepinephrine, 20 mM 
Experiment 1 4 hours 9.6 x 106 7.8 x 107 2.1 x 105  1.4 x 107 2.9 x 107 1.3 x 105 
Experiment 2 6 hours 4.0 x 107 6.3 x 107 6.9 x 104  4.8 x 107 1.5 x 107 9.8 x 104 
 
 
42 
 
References 
Alonso, G., K. Baptista, T. Ngo, and D. E. Taylor. 2005. Transcriptional organization of the 
temperature-sensitive transfer system from the IncHI1 plasmid R27. Microbiol. 
151:3563-3573.  
Bearson, B. L., and S. M. Bearson. 2008. The role of the QseC quorum-sensing sensor kinase in 
colonization and norepinephrine-enhanced motility of Salmonella enterica serovar 
Typhimurium. Microbiol. Pathog. 44:271-278.  
CDC. 2009. Facts about antibiotic resistance. http://www.cdc.gov/getsmart/antibiotic-use/fast-
facts.html.  
Chen, C., D. R. Brown, Y. Xie, B. T. Green, and M. Lyte. 2003. Catecholamines modulate 
Escherichia coli O157:H7 adherence to murine cecal mucosa. Shock 20:183-188. 
Chen, I., and D. Dubnau.2004.DNA Uptake During Bacterial Transformation. Microbiol.2: 241-
249. 
Clarke, M. B., and V. Sperandio. 2005. Events at the host-microbial interface of the 
gastrointestinal tract III. Cell-to-cell signaling among microbial flora, host, and 
pathogens: there is a whole lot of talking going on. Amer. J. Physiol. Gastrointest. Liver 
Physiol. 288:1105-1109. 
Couto, R. C., E. A. A. Carvalho, T. G. M. Pendorsa, E. R. Pendroso, M. C. Neto, F. M. Biscione. 
2007. A 10 -years prospective surveillance of nosocomial infections in neonatal intensive 
care units. Amer. J. Infect. Cont. 35:183 – 189. 
Dowd. S. E.2007.Escherichia coli O157:H7 gene expression in the presence of catecholamine 
norepinephrine. FEMS Microbiol. Lett.273: 214 –223.  
Durso L. M., D .R Smith, R.W Hutkins. 2004. Measurements of Fitness and Competition in 
Commensal Escherichia coli and E. coli O157:H7 Strains. Appl Environ Microbiol.70: 
6466-6472.  
Freestone, P. P., M. Lyte, C. P. Neal, A. F. Maggs, R. D. Haigh, and P. H. Williams. 2000. The 
mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in 
the presence of transferrin or lactoferrin. J. Bacteriol. 182: 6091-6098.  
Freestone, P. P., S.M. Sandrini, R. D. Haigh, M. Lyte.2008. Microbial endocrinology: how stress 
influences susceptibility to infection. Trends Microbiol. 16, 55-64. 
Furness J. B. 2000.Types of neurons in the enteric nervous system. J Auton Nerv Syst. 81: 87-96.  
Hemaiswarya, S., A. K. Kruthivent, M. Doble. 2008. Synergism between natural products and 
antibiotics against infectious diseases. Phytomed. 15: 639-652. 
43 
 
Karasek, R.A., R.S. Russell, and T. Theorell. 1982. Physiology of stress and regeneration in job 
related cardiovascular illness. Journal of Human Stress 8: 29-42. 
Karesh, W. B., A. Dobson, J. O. Lloyd-Smith, J. Lubroth, M. A. Dixon, M. Bennett, S. Aldrich, 
T. Harrington, P. Formenty, E. H. Loh, C. C. Machalaba, M. J. Thomas, D. L. Heymann. 
2012.Ecology of zoonoses. Natural and unnatural histories. Lancet 380: 1936-1945. 
Kohanski, M. K., D. J. Dwyer, J. J. Collins. 2010. How antibiotics kill bacteria: from targets to 
networks. Nat Rev Microbiol. 8: 423-435.     
Krantz, D.S., and Manuck, S.B. 1984. Acute psychophysiologic reactivity and risk of 
cardiovascular disease: A review and methodologic critique. Psychological Bulletin 96: 
435-464. 
Lyte, M., and S. Ernst. 1992. Catecholamine induced growth of gram negative bacteria. Life Sci. 
50:203-212.  
Lyte, M., B. P. Arulanandam, and C. D. Frank. 1996. Production of Shiga-like toxins by 
Escherichia coli O157:H7 can be influenced by the neuroendocrine hormone 
norepinephrine. J. Lab. Clin. Med.128:392-398. 
Lyte, M., A.K. Erickson, B.P. Arulanandam, C.D Frank, M.A. Crawford, D.H. Francis.1997. 
Norepinephrine-induced expression of the K99 pilus adhesin of enterotoxigenic 
Escherichia coli. Biochem. Biophys. Res. Comm.. 232: 682-686. 
Maeda, S., M I, T Ando, Y. Ishimoto, Y. Fujisawa, H. Takahashi, A. Matsuda, A. Sawamura, S. 
Kato. 2006. Horizontal transfer of nonconjugative plasmids in a colony biofilm of 
Escherichia coli. FEMS Microbiol. Lett.. 255: 115-120. 
Miller, H.J.M.T.2008. Development of the semi-synthetic penicillins and cephalosporins.31:189-
192.   
Nagy, B., P.Z. Fekete. 2005. Enterotoxigenic Escherichia coli in veterinary medicine. Int. J. 
Med. Microbiol. 295, 443-454. 
Ochman, H., J. G. Lawrence, and E. A. Groisman. 2000. Lateral gene transfer and the nature of 
bacterial innovation. Macmillan Magazines Ltd.405: 299-304. 
Peterson, G., A. Kumar, E. Gart, S. Narayanan. 2011. Catecholamines increase conjugative gene 
transfer between enteric bacteria. Microbial. Pathog. 51:1-8.  
Reading, N. C., and V. Sperandio. 2006. Quorum sensing: the many languages of bacteria. 
FEMS Microbiol. 254:1-11.   
Rozanski, A., C. N. Bairey, D. S. Krantz, J. Friedman, K. J. Resser, M. Morell, S. Hilton-
Chalfen, L. Hestrin, J Bietendorf, and D .S. Berman. 1988. Mental stress and the 
induction of silent myocardial ischemia in patients with coronary artery disease. N. Engl. 
J. Med. 318:1005-1011. 
44 
 
Sorensen S.J., M Bailey, L.H Hansen, N Kroer, S Wuertz. 2005. Studying plasmid horizontal 
transfer in situ: a critical review. Nat. Rev. Microbiol. 9: 700-710.  
Sperandio, V., A. G. Torres, and J. B. Kaper. 2002. Quorum sensing Escherichia coli regulators 
B and C (QseBC): a novel two-component regulatory system involved in the regulation 
of flagella and motility by quorum sensing in E. coli. Mol Microbiol. 43:809-821. 
Stins M. F., P.V Nemani, C Wass, K.S Kim. 1999. Escherichia coli binding to and invasion of 
brain microvascular endothelial cells derived from humans and rats of different ages. 
Infect. Immun. 67:5522-5525.   
Thomas, C. M., and K. M. Nielsen. 2005. Mechanisms of, and barriers to, horizontal gene 
transfer between bacteria. Nat. Rev. Microbiol. 3:711-721. 
Vicky Buchanan-Wollaston, J. E. P. F. C. 1987. The mob and Orit mobilization functions of a 
bacterial plasmid promote its transfer to plants. Nature 328: 172-175. 
Yusuf, S., Hawken, S, Ounpuu, S, Dans, T, Avezum, et al. 2004. Effect of potentially modifiable 
risk factors associated with myocardial infarction in 52 countries (the INTERHEART 
study): case-control study. Lancet 364: 937-952. 
 
 
